Saving Lives With Limula’s Machine For Industrializing Cell Therapy
“When you’re in the early stages of a gold rush, it makes sense to be the one providing the tools,” says Luc Henry, co-founder of Limula. The Swiss start-up, which is today announcing a $6.8 million funding round, wants to play... Read More →
Oxford Endovascular secures £8 million to take novel brain aneurysm tech to human trials
Parkwalk Advisors led the latest funding round investing £4.2 million alongside Norcliffe Capital, The University of Oxford, Oxford Science Enterprises (OSE) and Vulpes Investment Management. Oxford Endovascular today announces the successful completion of an 8 million GBP Series A+ funding... Read More →
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling featuring CellChorus
Chimeric antigen receptor (CAR) T cells used for the treatment of B cell malignancies can identify T cell subsets with superior clinical activity. Here, using infusion products of individuals with large B cell lymphoma, we integrated functional profiling using timelapse... Read More →
Celldom Lands $938K Phase II SBIR Grant From NCI
NEW YORK – Cell analysis firm Celldom said Tuesday that it has won a $938,647 Phase II Small Business Innovation Research grant from the National Cancer Institute. In an email, CEO and Cofounder Ben Yellen said the grant will fund development of... Read More →
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
BOSTON, May 14, 2024 (GLOBE NEWSWIRE) — MEACOR Inc. is pleased to announce the successful closing of its $15 million Series A funding round. This substantial investment supports MEACOR’s mission to offer a novel transcatheter approach for the treatment of... Read More →
May Health Raises $25 Million in Series B Funding to Advance Development for Ovarian Rebalancing Therapy
– Bpifrance and Trill Impact Ventures co-led the round, joining founding investor Sofinnova Partners, to support the company’s pivotal REBALANCE study evaluating Ovarian Rebalancing in women with infertility caused by PCOS PARIS, May 13, 2024–May Health, a clinical-stage medical device... Read More →
CLEW Medical Scores FDA Clearance for Next-Gen AI-Powered Patient Deterioration Prediction
– CLEW Medical, a provider of AI-driven clinical surveillance and predictive analytics, has achieved a breakthrough with FDA 510(k) clearance for its second-generation AI models for predicting patient deterioration. – The FDA clearance builds upon their pioneering achievement of being the first FDA-cleared... Read More →
Meet the medical device company that won a $100,000 business pitch competition featuring SafePush
A Metairie-based company that makes disposable devices to regulate the flow of medication won the Baton Rouge Entrepreneurship Week business pitch competition Thursday evening. SafePush took home the $100,000 investment prize and earned a spot in October’s Startup World Cup Grand... Read More →
Healionics Awarded $1.25M NIH Grant to Support Commercialization of STARgraft Vascular Graft
SEATTLE, WASHINGTON, USA, May 9, 2024 /EINPresswire.com/ — Healionics Corporation, a developer of biomaterial-based medical devices, today announced it has been awarded a $1.25 million Small Business Innovation Research grant by the National Heart, Lung, and Blood Institute to support... Read More →
Avenda touts study results of Unfold AI
AI healthcare firm Avenda Health is touting the results of a study showing how the company’s Unfold AI can identify prostate tumor margins and predict the efficacy of focal therapy treatments. Read More